BlackRock’s cbdMD YCBD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $801 | Hold |
1,080
| – | – | ﹤0.01% | 5564 |
|
|
2025
Q4 | $1.46K | Hold |
1,080
| – | – | ﹤0.01% | 5409 |
|
|
2025
Q3 | $1.31K | Sell |
1,080
-34
| -3% | -$28 | ﹤0.01% | 5341 |
|
|
2025
Q2 | $993 | Buy |
1,114
+1
| +0.1% | +$1 | ﹤0.01% | 5356 |
|
|
2025
Q1 | $2.05K | Hold |
1,113
| – | – | ﹤0.01% | 5299 |
|
|
2024
Q4 | $3.34K | Hold |
1,113
| – | – | ﹤0.01% | 5253 |
|
|
2024
Q3 | $4.18K | Sell |
1,113
-344
| -24% | -$1.5K | ﹤0.01% | 5055 |
|
|
2024
Q2 | $6.88K | Hold |
1,457
| – | – | ﹤0.01% | 5099 |
|
|
2024
Q1 | $10.8K | Hold |
1,457
| – | – | ﹤0.01% | 5079 |
|
|
2023
Q4 | $12.1K | Hold |
1,457
| – | – | ﹤0.01% | 5133 |
|
|
2023
Q3 | $12.1K | Hold |
1,457
| – | – | ﹤0.01% | 5188 |
|
|
2023
Q2 | $16.3K | Hold |
1,457
| – | – | ﹤0.01% | 5220 |
|
|
2023
Q1 | $102K | Sell |
1,457
-341
| -19% | -$31.6K | ﹤0.01% | 4947 |
|
|
2022
Q4 | $147K | Sell |
1,798
-7
| -0.4% | -$705 | ﹤0.01% | 4934 |
|
|
2022
Q3 | $146K | Sell |
1,805
-10
| -0.6% | -$1.44K | ﹤0.01% | 5062 |
|
|
2022
Q2 | $288K | Sell |
1,815
-233
| -11% | -$55.2K | ﹤0.01% | 4939 |
|
|
2022
Q1 | $766K | Sell |
2,048
-8
| -0.4% | -$2.7K | ﹤0.01% | 4756 |
|
|
2021
Q4 | $799K | Sell |
2,056
-5
| -0.2% | -$2.91K | ﹤0.01% | 4737 |
|
|
2021
Q3 | $1.54M | Buy |
2,061
+30
| +1% | +$25.1K | ﹤0.01% | 4426 |
|
|
2021
Q2 | $2.12M | Buy |
2,031
+23
| +1% | +$27.5K | ﹤0.01% | 4244 |
|
|
2021
Q1 | $2.99M | Buy |
2,008
+739
| +58% | +$1.07M | ﹤0.01% | 4159 |
|
|
2020
Q4 | $1.35M | Buy |
1,269
+9
| +0.7% | +$8.18K | ﹤0.01% | 4145 |
|
|
2020
Q3 | $907K | Sell |
1,260
-302
| -19% | -$288K | ﹤0.01% | 4140 |
|
|
2020
Q2 | $1.07M | Sell |
1,562
-2,496
| -62% | -$1.12M | ﹤0.01% | 4025 |
|
|
2020
Q1 | $1.36M | Buy |
4,058
+1,474
| +57% | +$581K | ﹤0.01% | 3778 |
|
|
2019
Q4 | $2.1M | Buy |
2,584
+3
| +0.1% | +$3.6K | ﹤0.01% | 3775 |
|
|
2019
Q3 | $3.68M | Buy |
2,581
+323
| +14% | +$518K | ﹤0.01% | 3575 |
|
|
2019
Q2 | $4.8M | Buy |
2,258
+1,349
| +148% | +$2.74M | ﹤0.01% | 3540 |
|
|
2019
Q1 | $1.45M | Sell |
909
-3
| -0.3% | -$4.72K | ﹤0.01% | 3803 |
|
|
2018
Q4 | $1.01M | Buy |
912
+876
| +2,433% | +$1.25M | ﹤0.01% | 3880 |
|
|
2018
Q3 | $47K | Buy |
36
+1
| +3% | +$1.27K | ﹤0.01% | 4549 |
|
|
2018
Q2 | $46K | Buy |
+35
| New | +$57.5K | ﹤0.01% | 4574 |
|
Other funds holding YCBD
WVP
CL
XT
CD
AA
VCM
VFT
CPIG
BlackRock's YCBD Position: Q1 2026 in Review
BlackRock held its cbdMD (YCBD) position steady in Q1 2026 at 1,080 shares worth $801. The position accounts for ﹤0.01% of the portfolio, ranked #5564.
BlackRock first reported a position in YCBD in Q2 2018 and has held it in 32 quarters since. The position peaked at $4.8M in Q2 2019. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.
- BlackRock held 1,080 shares of cbdMD worth $801 as of Q1 2026.
- BlackRock left its cbdMD share count unchanged in Q1 2026.
- cbdMD made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5564 holding.
- BlackRock first reported a position in cbdMD in Q2 2018 and has held it in 32 quarters since.
- BlackRock's cbdMD position peaked at $4.8M in Q2 2019.
- 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.